The cash flow of Westlake Corporation over the past 10 years
Chart Westlake Corporation: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Westlake Corporation's operating cash flow was $465M and its capital expenditures $995M, leaving free cash flow of -$530M. Free cash flow was above zero in 9 of the 10 years shown. It ranged from -$530M in fiscal 2025 to $2.29B in fiscal 2022. Capital expenditures were highest in fiscal 2022, at $1.11B.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $465M | $995M | -$530M |
| 2024ended Dec 31, 2024 | $1.31B | $1.01B | $306M |
| 2023ended Dec 31, 2023 | $2.34B | $1.03B | $1.3B |
| 2022ended Dec 31, 2022 | $3.4B | $1.11B | $2.29B |
| 2021ended Dec 31, 2021 | $2.39B | $658M | $1.74B |
| 2020ended Dec 31, 2020 | $1.3B | $525M | $772M |
| 2019ended Dec 31, 2019 | $1.3B | $787M | $514M |
| 2018ended Dec 31, 2018 | $1.41B | $702M | $707M |
| 2017ended Dec 31, 2017 | $1.53B | $577M | $951M |
| 2016ended Dec 31, 2016 | $867M | $629M | $238M |
Fiscal years as Westlake Corporation reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Westlake Corporation
- The revenue of Westlake Corporation
- The profitability of Westlake Corporation
- The debt of Westlake Corporation
- The dividends of Westlake Corporation
- All of Westlake Corporation's financials, charted
Companies of a similar size
- ADCAGREE REALTY CORPORATION
- UGIUGI CORPORATION
- ARWRARROWHEAD PHARMACEUTICALS, INC.
- LEVILEVI STRAUSS & CO
- VICRVICOR CORPORATION
Not investment advice. This page shows what Westlake Corporation filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.